Breast Cancer | Clinical

Triplet Therapy Shows Efficacy in Phase 1 Advanced Breast Cancer Trial

November 20, 2021

Evanthia Roussos Torres, MD, PhD, discusses the phase 1 study of the efficacy of entinostat administered in combination with nivolumab and ipilimumab for the treatment of locally advanced, metastatic, unresectable, or HER2-negative breast cancer.